AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02120352 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: HAART
Description: Higly-active antiretroviral therapy chosen by participant based on investigator recommendations and based on availability.
Study NCT02120352 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RPV
Description: Sterile white suspension containing 300 mg/mL of TMC278 as free base, poloxamer 338, sodium dihydrogen phosphate monohydrate, citric acid monohydrate, glucose monohydrate, sodium hydroxide, water for injection, packaged in a 2 mL USP Type I glass vial, for administration by IM injection.
Study NCT03007719 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorine F 18 Ara-G
Description: Given IV
Study NCT03007719 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/MR imaging
Study NCT03007719 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Magnetic Resonance Imaging
Description: Undergo PET/MR imaging
Study NCT02517086 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: functional compressive bandaging
Description: exercises for upper limb will be performed for an hour associated with the use of functional compressive bandaging. The functional compressive bandaging will be held with the volunteer sitting with ipsilateral upper limb resting on the support surgery. After hydration member a cotton mesh is used to prevent friction density 1cm strip of foam on the member to be wrapped. Elastic bandages of cotton will be involved 5 cm, 10 cm, 15 cm from the fingers to the axillary region multilayered
Study NCT02461628 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Malaria RDT & conditional voucher for ACT from retail sector
Description: Trained community health volunteers will offer eligible household members free malaria rapid diagnostic tests and a voucher allowing the purchase of a qualified ACT at a reduced fixed price in the retail sector conditional on a positive test
Study NCT01497704 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YN968D1
Description: Daily dosing of YN968D1 for treatment of solid tumors
Study NCT02088372 — intervention group
Intervention type: DEVICE
Intervention: Vanguard with E1 PS Bearing
Description: Evaluate Clinical Performance of Vanguard Knee with E1 Bearing in Korean Patient Population
Study NCT04910698 — intervention group
Intervention type: DRUG
Intervention: Antibiotic
Description: Antibiotic duration of treatment defined if the patient belonged to long course or short course group.
Study NCT04190810 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Inhibition
Description: Participants receive an Ipad, on which the app is installed. They are instructed to train for a period of three weeks for at least 15 minutes a day.
Study NCT04190810 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Classical AAT
Description: Participants receive an Ipad, on which the app is installed. They are instructed to train for a period of three weeks for at least 15 minutes a day.
Study NCT04190810 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Control
Description: Participants receive an Ipad, on which the app is installed. They are instructed to train for a period of three weeks for at least 15 minutes a day.
Study NCT02064114 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Intervention group
Description: Start of optimal management of risk factors, every 2 weeks for 6 months after atrial fibrillation ablation. And followed for a period of 3,6 and 12 months after the procedure.
Study NCT02064114 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: control group
Description: Followed for a period of 3,6 and 12 months after the procedure.
Study NCT04418843 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Standard Endoscopic Mucosal Resection
Description: Use of injected colloidal or saline solution to raise a lesion prior to polypectomy snare closed over a polyp with electrocautery
Study NCT04418843 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Cold Snare Endoscopic Mucosal Resection
Description: Use of injected colloidal or saline solution to raise a lesion prior to polypectomy snare closed over a polyp without electrocautery
Study NCT00925080 — intervention group
Intervention type: DEVICE
Intervention: IVBG
Description: Venous blood glucose measurement every 7.5 minutes for 72-hours
Study NCT00991224 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: WT-gag-TCR modified T cells
Description: Single dose of WT-gag-TCR modified T cells infused over 3 consecutive days.
Study NCT00991224 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: α/6-gag-TCR modified T cells
Description: Single dose of WT-gag-TCR modified T cells infused over 3 consecutive days.
Study NCT00991224 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: STI or Drug Holiday
Description: Subjects will stop taking antiviral medications for 16 weeks.
Study NCT03074201 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Spyglass DS Cholangioscope
Description: Cholangioscopy used instead of fluoroscopy-based ERCP to facilitate clearance of bile duct stones.
Study NCT04060004 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: Dry needling is a technique used by physiotherapists.
Study NCT04060004 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Sham dry needling
Description: Sham dry needling is a technique used by physiotherapists to compare the effects of dry needling.
Study NCT04060004 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Electrotherapy + therapeutic exercise
Description: Standard care of neck pain.
Study NCT03914534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Valproic Acid 500 MG
Description: Administration of 500 mg of Valproic Acid
Study NCT03914534 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Valcote 500 mg
Description: Administration of 500 mg of Valproic Acid
Study NCT01711658 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: IMRT
Description: Intensity modulated radiation therapy (IMRT), 35 fractions over 6 weeks, 6 fractions per week for 5 weeks and 5 fractions per week for 1 week, 2 Gy per fraction to total dose of 70 Gy
Study NCT01711658 — intervention group
Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: IMRT
Description: Intensity modulated radiation therapy (IMRT), 35 fractions over 6 weeks, 6 fractions per week for 5 weeks and 5 fractions per week for 1 week, 2 Gy per fraction to total dose of 70 Gy
Study NCT01711658 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Cisplatin
Description: 100 mg/m\^2 administered intravenously on days 8 and 29
Study NCT01711658 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cisplatin
Description: 100 mg/m\^2 administered intravenously on days 8 and 29
Study NCT01711658 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 1500 mg placebo daily by mouth or by feeding tube starting 7 days before IMRT for 7 weeks prior to and during IMRT and 3 months after completion of IMRT
Study NCT01711658 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lapatinib
Description: 1500 mg lapatinib by mouth or by feeding tube daily starting 7 days before IMRT for 7 weeks prior to and during IMRT and 3 months after completion of IMRT
Study NCT02527187 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 10 HEP/mL Betula verrucosa allergen extract
Description: The investigational product contained 10 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.
Study NCT02527187 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 25 HEP/mL Betula verrucosa allergen extract
Description: The investigational product contained 25 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.
Study NCT02527187 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 50 HEP/mL Betula verrucosa allergen extract
Description: The investigational product contained 50 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.
Study NCT02527187 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: 100 HEP/mL Betula verrucosa allergen extract
Description: The investigational product contained 100 HEP/mL Betula verrucosa allergen extract and was tested by administration onto skin. The test was carried out on the forearm following prick test technique.
Study NCT04789135 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ozone
Description: Treatment consists of direct instillation into the bladder of ozone gas, with concentration of 20µg / ml - 60ml via urethral catheter.
Study NCT03870672 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Contralaterally Controlled Functional Electrical Stimulation
Description: Contralaterally Controlled Functional Electrical Stimulation (CCFES) uses electrical stimulation to open the weak hand. Sticky patches called electrodes are placed on the participant's affected arm to stimulate the hand muscles, and a special glove is worn on the participant's strong hand and controls the stimulator. When the participant opens the gloved hand, stimulation opens the weak hand; when they close the gloved hand, stimulation turns off and the weak hand relaxes. During the clinic visits, participants will use CCFES to assist hand opening during functional training. During participant home sessions, they will use CCFES to perform hand opening exercise.
Study NCT03870672 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Contralaterally Controlled Functional Electrical Stimulation
Description: Contralaterally Controlled Functional Electrical Stimulation (CCFES) uses electrical stimulation to open the weak hand. Sticky patches called electrodes are placed on the participant's affected arm to stimulate the hand muscles, and a special glove is worn on the participant's strong hand and controls the stimulator. When the participant opens the gloved hand, stimulation opens the weak hand; when they close the gloved hand, stimulation turns off and the weak hand relaxes. During the clinic visits, participants will use CCFES to assist hand opening during functional training. During participant home sessions, they will use CCFES to perform hand opening exercise.
Study NCT03870672 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: New rTMS approach
Description: Participants in this arm will receive rTMS-based facilitation of the contralesional dorsal premotor cortex (cPMd) located in the non-stroke hemisphere before start of each session. High-frequency rTMS (5-Hz) will be delivered using 42 10-sec trains of 50 pulses each (total 2100 pulses) for a period of 24 minutes. Immediately after the completion of rTMS, participants will undergo upper limb training + CCFES for a total of one hour. Participants will receive these interventions 2 days a week for 12 weeks.
Study NCT01427972 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LY2623091
Description: Administered orally
Study NCT03870672 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional rTMS approach
Description: Facilitation of M1 will be achieved using 5Hz rTMS. High-frequency rTMS (5-Hz) will be delivered using 42 10-sec trains of 50 pulses each (total 2100 pulses) for a period of 24 minutes. Immediately after the completion of rTMS, participants will undergo upper limb training + CCFES for a total of one hour. Participants will receive these interventions 2 days a week for 12 weeks.
Study NCT03870672 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham rTMS approach
Description: In the sham rTMS group, ipsilesional motor hotspot will be targeted in half the patients and cHMC location will be targeted in the other half (based on random assignment). Immediately after the completion of rTMS, participants will undergo upper limb training + CCFES for a total of one hour. Participants will receive these interventions 2 days a week for 12 weeks.
Study NCT00005092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: IV over 2 hours on days 2 and 3
Study NCT00005092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Psoralen
Description: Psoralen treated T-cell allogeneic transplant on day 9
Study NCT04060004 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Electrotherapy + therapeutic exercise
Description: Standard care of neck pain.
Study NCT04060004 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Electrotherapy + therapeutic exercise
Description: Standard care of neck pain.
Study NCT00995098 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: early enteral nutrition
Description: Enteral nutrition will be administered within 24 hours of admission through naso-jejunal tube and continue for 7 days after admission. Naso-jejunal tube will be set up by endoscopy. X-ray will be used to place the distal end of the feeding tube and EN would not start until the distal end of the feeding tube has been placed at the remote end of Treitz ligament. Standard enteral nutrition liquid regimen (Nutrison Fibre) will be used. Patients are targeted to receive calories for 25 kcal/kg/day and nitrogen for 0.2g/kg/day.
Study NCT00995098 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Parenteral nutrition
Description: PN administration will start within 12 hours of admission and continue for 7 days after admission. Patients will receive calories for 25 kcal/kg and nitrogen for 0.2g/kg. Twenty percent of the calories will be provided by fat emulsion (LCT/MCT) and the remaining will be provided by dextrose. Nitrogen will be provided by balanced amino acids injection (Novamin). All PN components will be compounded into 3-liters bags under sterile conditions. Nutrition regimen will be administered through subclavian central venous catheter.
Study NCT04099498 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Online Program: Healthy Eating Promotion with Self-regulation
Description: Online-Intervention group
Study NCT04099498 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Enhanced Online Program: Healthy Eating Promotion with Self-regulation
Description: Enhanced-online-Intervention Group
Study NCT03196596 — intervention group
Intervention type: OTHER
Intervention: Computer simulation
Description: In these patients, a computer simulation model will be obtained based on pre procedural CT
Study NCT04717271 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Movement Guidance Group
Description: Participants of the MVG will received kinesthetic stimuli by manual assistance of the physiotherapist, which has the intention of guiding and improving the quality of movement during XBOX Kinect training for balance and gait.~Each session consisted of 10 minutes of warm-up and 40 minutes of XBOX Kinect training, using 4 different exergames.
Study NCT04717271 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: No Movement Guidance Group
Description: Participants of the NO-MVG will not received kinesthetic stimuli by manual assistance of the physiotherapist during XBOX Kinect training for balance and gait.~They will perform the exercises without any manual correction. Although, the physiotherapist will be present during all session to ensure their safety.~Each session consisted of 10 minutes of warm-up and 40 minutes of XBOX Kinect training, using 4 different exergames.
Study NCT01222819 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: filgrastim
Description: 5 mcg/kg (rounded to 300 mcg or 480 mcg)
Study NCT01222819 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: filgrastim
Description: 5 mcg/kg (rounded to 300 mcg or 480 mcg)
Study NCT04342676 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: k ras
Description: K ras
Study NCT01427972 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Eplerenone
Description: Administered orally
Study NCT03513367 — intervention group
Intervention type: OTHER
Intervention: Duchenne Muscular Dystrophy of the PedsQL ™ 3.0 scale
Description: Scaling in multidisciplinary consultations in the form of a self-administered questionnaire with the help of a third party (psychologist). The child and his / her parent complete the questionnaire independently. The result of the questionnaire will then be scored.~To validate the French translation of the pediatric module of Duchenne Muscular Dystrophy of the PedsQL ™ 3.0 scale. The validation process is confirmatory, the scale being widely used in English. The scale will measure the quality of life of the child using two independent assessments : children and their parents.
Study NCT03513367 — intervention group
Intervention type: OTHER
Intervention: The following data of motor function
Description: In parallel, the following data are collected on the day of the consultation: assessment of motor function (MFM, use of a wheelchair, age of loss of walking); assessment of respiratory function (EFR, FVC, respiratory assistance, type of respiratory aid); evaluation of cardiac function (FE); assessment of nutritional status (weight, height, BMI, nutritional support by gastrostomy), school status; ongoing drug treatments (corticosteroids, IEC).
Study NCT03290859 — intervention group
Intervention type: PROCEDURE
Intervention: Titrate propofol monotherapy infusion to effect
Description: Train anesthesia providers in a standardized protocol for titrating propofol infusion to effect.
Study NCT03041584 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Guided placement
Description: implant placement with use of guide
Study NCT00005092 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Thiotepa
Description: IV over 2 hours on day 1
Study NCT00005092 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Allogeneic bone marrow transplantation
Description: Preserved stem cell or bone marrow allogeneic transplant plus psoralen treated T-cell allogeneic transplant on day 9
Study NCT00005092 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: In vitro-treated peripheral blood stem cell transplantation (PBSCT)
Description: Preserved stem cell or bone marrow allogeneic transplant plus psoralen treated T-cell allogeneic transplant on day 9
Study NCT00005092 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy (RT)
Description: Whole body radiotherapy on days 5-8.
Study NCT03041584 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Non-guided placement
Description: conventional implant placement
Study NCT03041584 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Astra Tech TX implant
Study NCT03041584 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Astra Tech TX implant
Study NCT02634892 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PRO-TECT
Description: Patient will be placed on ROHO SOFFLEX2 mattress with has been modified with gel cushions in the sacral region for heal dissipation by standard closed system cooling pad
Study NCT04014439 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Ratio of Neutrophil to Lymphocyte
Description: Each patient was examined for a blood sample of 6 ml of venous blood taken from the cubital vein using a vacuum tube without anticoagulants. Blood samples were centrifuged at a speed of 3500 rpm for 20 minutes. Samples are processed with abbott® devices, to obtain neutrophil and serum lymphocyte levels. Plasma samples are stored in the refrigerator -20 C. The patient's diaphragm thickness was measured on days 0, 3, 5 and then the measurement was compared. Diaphragm thickness was measured in patients using mechanical ventilation in intensive care rooms.
Study NCT04014439 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Level of Prealbumin Serum
Description: Each patient was examined for a blood sample of 6 ml of venous blood taken from the cubital vein using a vacuum tube without anticoagulants. Blood samples were centrifuged at a speed of 3500 rpm for 20 minutes. Samples are processed with abbott® devices, to obtain neutrophil and serum lymphocyte levels. Plasma samples are stored in the refrigerator -20 C. The patient's diaphragm thickness was measured on days 0, 3, 5 and then the measurement was compared. Diaphragm thickness was measured in patients using mechanical ventilation in intensive care rooms.
Study NCT01073358 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Routine hilar lymphadenectomy
Description: Hilar lymphadenectomy is performed before actual resection of the colorectal liver metastases
Study NCT04255706 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: biometric measurement IOLMaster 700
Description: Three biometric measurements will be performed with 3 devices for all the patients included
Study NCT04255706 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: biometric measurement Lenstar LS 700
Description: Three biometric measurements will be performed with 3 devices for all the patients included
Study NCT04255706 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: biometric measurement Anterion Heildelberg
Description: Three biometric measurements will be performed with 3 devices for all the patients included
Study NCT01965665 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MediHoney HCS dressing
Study NCT00858117 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Alemtuzumab
Description: Alemtuzumab administered subcutaneously 30mg per day, 3 days per week for 18 weeks
Study NCT00858117 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Rituximab administered intravenously at 375mg/m2 every 2 weeks for 18 weeks
Study NCT03094169 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AVID100 IV
Description: AVID100 is administered once every 3 weeks